We have redirected you to the United States (US English) site. If you believe this is in error, you can change your selection.

To access this area you must be a Healthcare Professional.

I am not a Healthcare Professional

Bulkamid for Healthcare Professionals

Advancing Stress Urinary Incontinence Treatment

A Unique Bulking Agent for the Treatment of Female SUI

  • Unique Composition

    Homogenous hydrogel consisting of 97.5% water and 2.5% cross-linked polyacrylamide.1

  • Precision Delivery System

    Allows for reproducible placement of the Bulkamid cushions under direct vision.

  • Efficacious, Durable, Safe

    92% of women report being cured or improved at 12 months2, with durability demonstrated at seven years3 and no serious adverse events.

What Makes Bulkamid Different

Durability Demonstrated to Seven Years 3

  • 388 patients followed out to a minimum of seven years

  • 81% received no further treatment at seven years

  • 2 out of 3 women reported being cured or improved at seven years

Proven Efficacy and Safety

In a head-to-head RCT2 evaluating Bulkamid versus TVT (tension-free vaginal tape) in 224 women with SUI, Bulkamid demonstrated excellent efficacy with no serious complications at 1 year.

An Excellent Safety Profile

An extremely low peri and postoperative complication rate in studies up to 7 years.

Adverse Events0 (0 %)1 (0.4%)*0 (0 %)0 (0 %)0 (0 %)0 (0 %)0 (0 %)0 (0 %)
Retention2 (1.4 %)13 (5.7%)1 (0.4 %)0 (0 %)1 (0.8 %)0 (0 %)3 (2.8 %)0 (0 %)
Infection0 (0 %)8 (3.5%)4 (1.6 %)1 (2.6 %)2 (1.6 %)2 (3.6 %)0 (0 %)11 (3.5 %)
Follow Up24 Months12 Months5 Years6 Months3 Months12 Months12 Months7 Years

The SUI Treatment Option Preferred by Women

When given the choice, 64% of women with SUI would prefer a Bulking agent for treatment of their condition10

Discover More

If you feel Bulkamid may be an option for your patients, visit Bulkamid Academy to take the first step in your training journey or please contact your local representative here.

Bulkamid AcademyContact us